Options
Indian Patent Office rejects Saxagliptin compulsory license application
Date Issued
2016
Author(s)
Agarwal, D
Agarwal, R
Abstract
The Controller of Patents (Patent Office, Mumbai) rejected Lee Pharma's compulsory licence application for AstraZeneca's Saxagliptin for failure to provide evidence leading to the application of any of the grounds under section 84 of the Patents Act 1970.
Volume
11